| P50 | author | François Moreau-Gaudry | Q91253887 |
| P2093 | author name string | Nicolas Petit | |
| | Hubert de Verneuil | |
| | Pierre Dubus | |
| | Yann Duchartre | |
| | Emmanuel Richard | |
| | Magalie Lalanne | |
| | Corrine Moya | |
| P2860 | cites work | Liver disease in erythropoietic protoporphyria: insights and implications for management | Q36759851 |
| | Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection. | Q40775938 |
| | Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy | Q45859178 |
| | Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis | Q45882047 |
| | Bone marrow-derived cells promote liver regeneration in mice with erythropoietic protoporphyria | Q50572244 |
| | A novel method of myeloablation to enhance engraftment of adult bone marrow cells in newborn mice | Q73266655 |
| | Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria | Q78177007 |
| | Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria | Q78813037 |
| | Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase | Q81283806 |
| | A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria | Q81333559 |
| | The role for BMT in erythropoietic protoporphyria | Q84068700 |
| | C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload | Q24642289 |
| | Erythropoietic porphyrias: animal models and update in gene-based therapies | Q28282994 |
| | Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease | Q28586627 |
| | Reversion of hepatobiliary alterations By bone marrow transplantation in a murine model of erythropoietic protoporphyria | Q33180600 |
| | Liver transplantation for erythropoietic protoporphyria liver disease. | Q34562963 |
| | Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria | Q34572228 |
| | Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria | Q34680002 |
| | Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis. | Q36656649 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erythropoietic protoporphyria | Q1759600 |
| | murine model | Q122890741 |
| P304 | page(s) | 162-170 | |
| P577 | publication date | 2010-10-23 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria | |
| P478 | volume | 55 | |